|
|||||
|
|
Prior authorization for biologic disease‐modifying antirheumatic drugs: A description of US medicaid programs |
|
| Authors: | Michael A. Fischer Jennifer M. Polinski Amber D. Servi Jessica Agnew‐Blais Liljana Kaci Daniel H. Solomon |
| Affiliation: | 1. Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;2. Dr. Solomon has served as an unpaid member of advisory boards for Abbott and Amgen. |
| Abstract: | |
| Keywords: | |